Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

Saved in:
Bibliographic Details
Title: Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Authors: Barrett JR; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Belij-Rammerstorfer S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Dold C; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Ewer KJ; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Folegatti PM; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbride C; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Halkerston R; Public Health England, Salisbury, UK., Hill J; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Jenkin D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Daniel.Jenkin@ndm.ox.ac.uk., Stockdale L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Verheul MK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Angus B; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Bellamy D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Berrie E; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Bibi S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Bittaye M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Carroll MW; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Cavell B; Public Health England, Salisbury, UK., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Edwards N; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Flaxman A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Fuskova M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gorringe A; Public Health England, Salisbury, UK., Hallis B; Public Health England, Salisbury, UK., Kerridge S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Lawrie AM; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Linder A; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Madhavan M; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Makinson R; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Mellors J; Public Health England, Salisbury, UK., Minassian A; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Moore M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Mujadidi Y; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Poulton I; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Rollier CS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Song R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Tarrant R; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Taylor S; Public Health England, Salisbury, UK., Thomas KM; Public Health England, Salisbury, UK., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK., Watson MEE; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Wright D; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Douglas AD; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Green CM; Clinical BioManufacturing Facility, The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Hill AVS; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Lambe T; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gilbert S; The Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK. Andrew.Pollard@paediatrics.ox.ac.uk.
Corporate Authors: Oxford COVID Vaccine Trial Group
Source: Nature medicine [Nat Med] 2021 Jun; Vol. 27 (6), pp. 1113.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-170X
DOI:10.1038/s41591-021-01372-z